期刊文献+

帕金森病患者血尿酸水平与认知功能、炎性因子及神经细胞因子的相关性 被引量:13

The correlation between serum uric acid level and cognitive function,inflammatory factors and neurocytokines in patients with Parkinson's disease
下载PDF
导出
摘要 目的分析帕金森病(PD)患者血尿酸水平与认知功能、炎性因子及神经细胞因子的相关性。方法选择2015年2月-2017年12月重庆市人民医院神经内科首次诊断为PD的患者作为PD组(n=100),同期在医院体检的健康志愿者作为健康对照组(n=80)。采集2组空腹血测定尿酸、炎性因子、神经细胞因子的水平,采用蒙特利尔认知功能评估(MoCA)量表评价认知功能。结果 PD组患者的血尿酸、BDNF、GDNF、EGF、IGF-1的水平以及认知功能评分均低于健康对照组(t/P=15. 839/0. 000、23. 020/0. 000、15. 348/0. 000、20. 210/0. 000、11. 135/0. 000、19.313/0.000),血IFN-γ、IL-1β、IL-6、YKL-40、sTNFR-1的水平高于健康对照组(t/P=26. 466/0. 000、40. 910/0. 000、27.475/0.000、19.761/0.000、14.311/0.000);PD组患者的血尿酸水平与IFN-γ、IL-1β、IL-6、YKL-40、sTNFR-1水平呈负相关(r/P=-0.614/0.007、-0.551/0.014、-0.476/0.022、-0.535/0.016、-0.418/0. 028),与BDNF、GDNF、EGF、IGF-1的水平以及认知功能评分呈正相关(r/P=0. 552/0. 014、0. 489/0. 020、0.452/0. 025、0. 591/0. 011、0. 394/0.031)。结论帕金森病患者血尿酸水平降低与认知功能损害、炎性因子及神经细胞因子异常分泌有关。 Objective To analyze the correlation between serum uric acid level and cognitive function,inflammatory factors and neurocytokines in patients with Parkinson's disease (PD). Methods From February 2015 to December 2017,patients with first diagnosed PD in the Department of Neurology of Chongqing People's Hospital were selected as PD group ( n =100),and healthy volunteers who underwent physical examination in the same period were selected as healthy control group ( n =80). The levels of uric acid,inflammatory factors and neurocytokines were measured in two groups of fasting blood. The cognitive function was evaluated by Montreal Cognitive Function Assessment (MoCA). Results The levels of serum uric acid,BDNF,GDNF,EGF,IGF-1 and cognitive function scores in the PD group were lower than those in the healthy control group ( t/P =15.839/0.000, t/P =23.020/0.000, t/P =15.348/ 0.000, t/P =20.210/0.000, t/P =11.135/0.000, t/P = 19.313/0.000),the levels of blood IFN-γ,IL-1β,IL-6,YKL-40,sTNFR-1 were higher than healthy controls ( t/P =26.466 /0.000, t/P =40.910/0.000, t/P =27.475/0.000, t/P =19.761/0.000, t/P =14.311/0.000);blood uric acid level and IFN-γ in PD patients,There was a negative correlation between IL-1β,IL-6,YKL-40 and sTNFR-1 levels ( r/P =-0.614 /0.007, r/P =-0.551/0.014, r/P =-0.476/0.022, r/P =-0.535/ 0.016, r/P =-0.418/0.028),positively correlated with the levels of BDNF,GDNF,EGF,IGF-1 and cognitive function scores ( r/P =0.552/0.014, r/P =0.489/0.020 , r/P =0.452/0.025, r/P =0.591/0.011,r/P =0.394/0.031). Conclusion The decrease of serum uric acid level in patients with Parkinson's disease is related to cognitive impairment,abnormal secretion of inflammatory factors and neurocytokines.
作者 彭雪梅 邓婧 李琴 蔡敏 PENG Xuemei;DENG Jing;LI Qin;CAI Min(Department of Neurology,Chongqing People's Hospital,Chongqing 400013,China)
出处 《疑难病杂志》 CAS 2019年第2期119-122,共4页 Chinese Journal of Difficult and Complicated Cases
基金 重庆市医学科研计划项目(20143008)
关键词 帕金森病 血尿酸 认知功能 炎性因子 神经细胞因子 Parkinson's disease Uric acid Cognitive function Inflammatory factors Neural cytokine
  • 相关文献

参考文献10

二级参考文献112

  • 1张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:616
  • 2孙庆,徐昭.腹部推拿治疗广泛性焦虑症的临床研究[J].天津中医药,2007,24(3):215-217. 被引量:29
  • 3Hughes AJ,Daniel SE,Kilford L. Accuracy of clinical diagnosis of idiopathic Parkinson ' s disease:a clinico-pathological study of 100 cases[J].Journal of Neurology Neurosurgery and Psychiatry,1992,(03):181-184.
  • 4Constantinescu R,Zetterberg H,Holmberg B. Levels of brain re-lated proteins in cerebrospinal fluid:an aid in the differential diagnosis of parkinsonian disorders[J].Parkinsonism and Related Disorders,2009,(03):205-212.
  • 5Levine AJ,Harris CR,Puzio-Kuter AM. The interfaces between signal transduction pathways:IGF-1/mTor,p53 and the Parkinson Disease pathway[J].Oncotarget,2012,(11):1301-1307.
  • 6Chung JY,Lee SJ,Lee SH. Direct interaction of α-synuclein and AKT regulates IGF-1 signaling:implication of Parkinson disease[J].Neurosignals,2011,(02):86-96.
  • 7Zhang ZX, Roman GC, Hong Z,et al. Parkinson's disease inChina: prevalence in Beijing, Xian, and Shanghai[ J]. Lancet,2005,365(9459): 595-597.
  • 8Postuma RB, Berg D, Stem M, et al. MDS clinical diagnosticcriteria for Parkinson、disease[ J]. Mov Disord, 2015,30( 12):1591-1601. DOI: 10.1002/mds.26424.
  • 9Chaudhuri KR, Healy DG, Schapira AH, et al. Non-motorsymptoms of Parkinson's disease : diagnosis and management[ J ].Lancet Neurol, 2006,5(3): 235-245.
  • 10Goetz CG,Tilley BC, Shaftman SR,et al. Movement DisorderSociety-sponsored revision of the Unified Parkinson; s DiseaseRating Scale ( MDS-UPDRS) . scale presentation and clinimetrictesting results [ J ]. Mov Disord, 2008 , 23 ( 15): 2129-2170.DOI: 10.1002/mds. 22340.

共引文献1229

同被引文献143

引证文献13

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部